Evidence map›Paper›PMID 36898931›Full record

Trial reportVaccine2023

The interplay between WASH practices and vaccination with oral cholera vaccines in protecting against cholera in urban Bangladesh: Reanalysis of a cluster-randomized trial.

Fahima Chowdhury, Asma Binte Aziz, Faisal Ahmmed, Tasnuva Ahmed, Sophie Sy Kang, Justin Im, Juyeon Park, Birkneh Tilahun Tadesse, Md Taufiqul Islam, Deok Ryun Kim and 11 more

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Vaccine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07685574 (Case-area Targeted Interventions), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07685574 narecruitingnot on this mapstarted 2024, after this paper: background citation

Case-area Targeted Interventions (CATIs) Among Household Contacts and Neighbouring Households After Defining Cholera Hotspot Areas in Bangladesh: The Effectiveness of OCV and Potential Impact on Cholera Control

TypeinterventionalSponsorInternational Centre for Diarrhoeal Disease Research, BangladeshRan2024 to 2029Enrolled68,400ConditionsCholera, Methodology StudyArmsCholvax
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 4 institutions in 5 countries.

Fahima ChowdhuryInternational Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh; Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia. Electronic address: fchowdhury@icddrb.org.
Asma Binte AzizInternational Vaccine Institute, Seoul, Republic of Korea.
Faisal AhmmedInternational Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.
Tasnuva AhmedInternational Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.
Sophie Sy KangInternational Vaccine Institute, Seoul, Republic of Korea.
Justin ImInternational Vaccine Institute, Seoul, Republic of Korea.
Juyeon ParkInternational Vaccine Institute, Seoul, Republic of Korea; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Birkneh Tilahun TadesseInternational Vaccine Institute, Seoul, Republic of Korea.
Md Taufiqul IslamInternational Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.
Deok Ryun KimInternational Vaccine Institute, Seoul, Republic of Korea.
Masuma HoqueInternational Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.
Gideok PakInternational Vaccine Institute, Seoul, Republic of Korea.
Farhana KhanamInternational Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.
Nigel A J McMillanMenzies Health Institute Queensland, Griffith University, Gold Coast, Australia.
Xinxue LiuOxford Vaccine Group, Department of Pediatrics, University of Oxford, Oxford OX3 9DU, United Kingdom.
Khalequ ZamanInternational Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.
Ashraful Islam KhanInternational Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.
Jerome H KimInternational Vaccine Institute, Seoul, Republic of Korea.
Florian MarksInternational Vaccine Institute, Seoul, Republic of Korea; Department of Medicine, University of Cambridge, Cambridge, United Kingdom; University of Antananarivo, Antananarivo, Madagascar.
Firdausi QadriInternational Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.
John D ClemensInternational Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh; International Vaccine Institute, Seoul, Republic of Korea; UCLA Fielding School of Public Health, Los Angeles, CA 90095-1772, USA.
International Centre for Diarrhoeal Disease Research · BDInternational Vaccine Institute · KRGriffith University · AUUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current global initiative to end Cholera by 2030 emphasizes the use of oral cholera vaccine (OCV) combined with feasible household Water-Sanitation-Hygiene (WASH) interventions. However, little is known about how improved WASH practices and behaviors and OCV interact to reduce the risk of cholera. We reanalyzed two arms of a cluster-randomized trial in urban Bangladesh, to evaluate the effectiveness of OCV given as a 2-dose regimen. One arm (30 clusters, n = 94,675) was randomized to vaccination of persons aged one year and older with OCV, and the other arm (30 clusters, n = 80,056) to no intervention. We evaluated the prevention of cholera by household WASH, classified at baseline using a previously validated rule, and OCV over 2 years of follow-up. When analyzed by assignment to OCV clusters rather than receipt of OCV, in comparison to persons living in "Not Better WASH" households in the control clusters, reduction of severe cholera (the primary outcome) was similar for persons in "Not Better WASH" households in vaccine clusters (46%, 95% CI:24,62), for persons in "Better WASH" households in the control clusters (48%, 95% CI:25,64), and for persons in "Better WASH" households in the vaccine clusters (48%, 95% CI:16,67). In contrast, when analyzed by actual receipt of a complete OCV regimen, , in comparison to persons in "Not Better WASH" households in the control clusters, protection against severe cholera increased steadily from 39% (95% CI:13,58) in residents of "Better WASH" households in the control clusters to 57% (95% CI:35,72) in vaccinated persons in "Not Better WASH" households to 63% (95% CI:21,83) in vaccinated persons in "Better WASH" households. This analysis suggests that improved household WASH and OCV received may interact to provide greater protection against cholera. However, the divergence between findings related to intent to vaccinate versus those pertaining to actual receipt of OCV underscores the need for further research on this topic.

Indexed as

CholeraCholera VaccinesAdministration, OralBangladeshHumansHygieneSanitationVaccinationWaterCholera VaccinesWaterCholeraCluster randomized trialsOral cholera vaccineVaccine effectivenessWASH

Identifiers

PMID36898931
PMCPMC10102718
OpenAlexW4323544602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.